This 10% Dividend Stock Pays Cash Every Month

NorthWest Healthcare REIT offers shareholders a dividend yield of 10.4%, making it attractive to income-seeking investors.

| More on:

Monthly paying dividend stocks with attractive yields can help you earn a passive-income stream. As shareholders receive a monthly payout, the dividends can be used to offset expenses such as utility bills.  

However, investors should note that dividends are not guaranteed and can be reduced or suspended entirely if economic conditions deteriorate. For instance, several TSX oil companies suspended dividend payouts when oil prices declined rapidly three years back.

But dividends are paid by companies that generate consistent profits and stable cash flows. Moreover, dividend stocks have historically outpaced broader indices over time, as investors can also benefit from capital gains.

Here is one such TSX stock with a 10% dividend yield and a monthly payout.

NorthWest Healthcare Properties REIT

A real estate investment trust (REIT), NorthWest Healthcare (TSX:NWH.UN), currently pays investors a monthly dividend of $0.067 per share, translating to a forward yield of 10.4%. With a portfolio of 233 properties spanning 18.6 million square feet, NorthWest Healthcare REIT offers you exposure to a recession-resistant sector.

Around 83% of NorthWest’s rents are indexed to inflation, and 80% of its tenants are supported by government funding. With 2,100 tenants across eight countries, NorthWest Healthcare is well diversified. It ended the first quarter (Q1) with an occupancy rate of 97% and a weighted average lease expiry of 13.8 years, providing investors with significant cash flow visibility.

The company’s global scale makes it a partner of choice for leading operators. It completed $1.1 billion of global acquisitions in 2022 and entered the U.S. market, which is the largest healthcare market globally.

NorthWest Healthcare aims to provide sustainable and growing cash distributions by expanding its real estate portfolio. It already owns and operates properties in North America, Brazil, Europe, Australia, and New Zealand.

It is focused on growth opportunities within the existing portfolio and via accretive acquisitions in target markets, allowing the REIT to expand its assets base and maximize shareholder value.

After a difficult year in 2022, NorthWest Healthcare expects to increase adjusted funds flow from operations by 10% in 2023. It has also identified $220 million of non-core assets, which would be offloaded this year, providing it with additional flexibility.

What’s next for NorthWest Healthcare REIT and investors?

A period of rising interest rates will act as a headwind for NorthWest REIT and its peers. Typically, REITs use leverage to fund their acquisitions. As the cost of debt has increased significantly, NorthWest’s mortgage and loan interest expense has risen to over $51 million in Q1 of 2023, up from $23.38 million in the year-ago period.

But NorthWest emphasized, “The REIT has entered $892 million of hedging arrangements to fix interest rates on floating rate, foreign currency debt facilities which will immediately stabilize results and increase AFFO by $0.03 to $0.05 per unit.” It also refinanced $1.7 billion of expiring debt and increased fixed-rate exposure to 63% of total debt.

The Canadian REIT has underperformed broader markets in the past decade. Since June 2013, NorthWest Healthcare has returned just 30% to shareholders after adjusting for dividends. The TSX Index has surged 120% in this period.

Down 47% from all-time highs, NorthWest Healthcare stock is currently trading at a discount of 38.5% to consensus price target estimates.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends NorthWest Healthcare Properties Real Estate Investment Trust. The Motley Fool has a disclosure policy.

More on Dividend Stocks

clock time
Dividend Stocks

Time to Buy This Canadian Stock That Hasn’t Been This Cheap in Years

This dividend stock may be down, but certainly do not count it out, especially as it holds a place in…

Read more »

Paper Canadian currency of various denominations
Dividend Stocks

Is Brookfield Infrastructure Stock a Buy for its 5% Dividend Yield?

Brookfield Infrastructure's 5% yield is attractive, but it's just the tip of the iceberg for why it's one of the…

Read more »

senior man smiles next to a light-filled window
Dividend Stocks

Buy 4,167 Shares of 1 Dividend Stock, Create $325/Month in Passive Income

This dividend stock has one strong outlook. Right now could be the best time to grab it while it offers…

Read more »

ETF stands for Exchange Traded Fund
Dividend Stocks

4 Passive Income ETFs to Buy and Hold Forever

These 4 funds are ideal for long-term investors seeking to simplify the process of investing in high-quality, dividend-paying companies while…

Read more »

sale discount best price
Dividend Stocks

2 Delectable Dividend Stocks Down up to 17% to Buy Immediately

These two dividend stocks may be down, but each are making some strong changes for today's investor.

Read more »

Paper Canadian currency of various denominations
Dividend Stocks

2 Top Canadian Dividend Stocks to Buy on a Pullback

These stocks deserve to be on your radar today.

Read more »

ways to boost income
Dividend Stocks

This 10.18% Dividend Stock Is My Pick for Immediate Income

This dividend stock offers an impressive dividend yield, but is that enough for investors to consider long term?

Read more »

Confused person shrugging
Dividend Stocks

Telus: Buy, Sell, or Hold in 2025?

Telus is down 20% in the past year. Is the stock now undervalued?

Read more »